These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4338981)

  • 21. [Physico-chemical and immunobiological properties of the ribosomal preparations of Clostridium perfringens, type A].
    Efimova MG
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (2):46-9. PubMed ID: 9662798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Clostridium toxoids, especially of Clostridium perfringens toxoid, on mouse transplanted tumors.
    Sasaki T; Chihara G; Takasuka N; Suzuki S
    Gan; 1976 Apr; 67(2):275-7. PubMed ID: 184006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preparation and evaluation of immunogenic properties of Clostridium perfringens type A toxoid].
    Rymkiewicz D; Sawicki J; Brühl A; Sochańska R
    Med Dosw Mikrobiol; 1979; 31(2):95-102. PubMed ID: 228130
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunogenicity of purified toxoid of Habu (Trimeresurus flavoviridis) venom.
    Kondo H; Kondo S; Sadahiro S; Yamauchi K; Murata R
    Jpn J Med Sci Biol; 1972 Jun; 25(3):202-5. PubMed ID: 4539442
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunogenic properties of Clostridium perfringens type A anatheta-hemolysin].
    Sergeeva TI; Dolgikh MS; Blagoveshchenskiĭ VA
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):71-5. PubMed ID: 6275640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Characteristics of the immunologic response of animals to Clostridium perfringens anatoxin].
    Petrov RV; Shemanova GF; Panteleev EI; Dmitrieva LN; Vlasova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1977 May; (5):71-4. PubMed ID: 197752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperimmunization of horses with alpha toxoid of Clostridium perfringens.
    Yanamoto A; Ito A; Murata R; Uematsu N; Nagai K
    Jpn J Med Sci Biol; 1970 Apr; 23(2):111-5. PubMed ID: 4318177
    [No Abstract]   [Full Text] [Related]  

  • 28. Morphological and histochemical changes during the immunization of guinea-pigs with Clostridium oedematiens toxoid.
    YERMAN BA
    Zh Mikrobiol Epidemiol Immunobiol; 1961; 32():1272-6. PubMed ID: 14040375
    [No Abstract]   [Full Text] [Related]  

  • 29. [A comparative study of the antigenic and immunogenic properties of the anatoxin of Cl. perfringens, concentrated and purified by various methods].
    Larina IA; Samsonova VS; Volkova ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Apr; 45(4):86-9. PubMed ID: 4309741
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of alpha-toxin of Clostridium perfringens in experimental gas gangrene in guinea pigs.
    Kameyama S; Sato H; Murata R
    Jpn J Med Sci Biol; 1972 Jun; 25(3):200. PubMed ID: 4345498
    [No Abstract]   [Full Text] [Related]  

  • 31. Potency testing Clostridium novyi-containing bacterins: comparison of immunologic response in guinea pigs and sheep.
    Macheak ME; Claus KD; Maloy SE
    Am J Vet Res; 1972 Jun; 33(6):1201-8. PubMed ID: 5022400
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pseudomonas aeruginosa toxoid].
    Ianishevskaia MN
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):27-32. PubMed ID: 3922181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Toxins and anatoxins of Clostridium perfringens].
    Cherkas GP; Kalinichenko MF; Biriukova SV; Podgornaia LG
    Mikrobiol Zh; 1971; 33(2):173-5. PubMed ID: 4326475
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunogenic properties of Cl. perfringens anatoxins obtained from purified toxins].
    Dmitrieva LN; Shemanova GF; Akhundova KA; Vlasova EV; Il'nitskaia KA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Nov; (11):134-6. PubMed ID: 176848
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental preventive properties of a complex of Pseudomonas aeruginosa and Clostridium tetani anatoxins].
    Podgornaia LG; Dziuban NF; Kalinichenko NF; Isaeva SIa
    Mikrobiol Zh (1978); 1987; 49(5):55-8. PubMed ID: 3150503
    [No Abstract]   [Full Text] [Related]  

  • 36. [Toxoids of botulinum toxin type G].
    Puig de Centorbi ON; Ciccarelli AS; Giménez DF
    Rev Argent Microbiol; 1980; 12(1):10-7. PubMed ID: 6755549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of the interrelationship between the content of immunizing units and the immunogenicity of C1. perfringens anatoxins].
    Nenashev VP; Akhundova KA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Aug; (8):93-6. PubMed ID: 173119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Method of determinating the protective capacity of C1. perfringens toxoid].
    Akhundova KA; Nenashev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Apr; (4):43-7. PubMed ID: 176851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sensitizing properties of purified concentrated Cl. perfringens toxoids].
    Kalinichenko NF; Starobinets ZG; Podgornaia LG; Biriukova SV
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Oct; 48(10):113-5. PubMed ID: 4330843
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on immunogenicity of toxoxids from Habu (Trimeresurus flavoviridis) venom.
    Sadahiro S; Kondo S; Yamauchi K; Kondo H; Murata R
    Jpn J Med Sci Biol; 1970 Aug; 23(4):285-9. PubMed ID: 5312799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.